Delivery Hero's Korean unit sale hits dead end

Delivery Hero SE on Thursday postponed the deadline again for the final bidding of South Korea's Yogiyo, amid market doubts over the country's No. 2...

Failed M&As in Korea now draw excess of candidates with better outlook

South Korea’s M&A market is heating up as the outlook for the global economic recovery is becoming more comfortable this year.The M&A ...

Celltrion, Mirae to take largest stake in UK biotech firm

South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...

Samsung Bio plans to manufacture mRNA drug substance from 2022

Samsung Biologics will be entering the drug substance segment of the COVID-19 vaccine contract manufacturing business. According to industry sources...

SK Bioscience secures up to $173.4 mn from CEPI for vaccine development

SK Bioscience Co. has secured additional funding for phase III clinical trial of GBP510, its COVID-19 vaccine candidate jointly developed with the I...

Genexine exports COVID vaccine candidate to Indonesia

Genexine Inc., one of the five South Korean pharmaceutical companies whose COVID-19 vaccine candidates have entered clinical trials, will export its...

SK injects $200 mn into Roivant partnership for new drug development

SK Holdings Co., the holding company of South Korean conglomerate SK Group, has become the first Korean company to foray into the targeted protein d...

Celltrion to co-develop pill-type autoimmune disease drug with UK startup

Biosimilar maker Celltrion Inc. has agreed to develop a tablet-type treatment for autoimmune diseases jointly with the UK biotech startup Intract Phar...

NPS tipped to restart CIO selection process in hunt for new candidates

The National Pension Service (NPS) has failed to choose a chief investment officer from 16 applicants and is likely to restart the selection process f...

NPS kicks off CIO search process; no strong candidate yet

The National Pension Service (NPS), the world’s third-largest pension scheme, began the process of searching its new chief investment officer this wee...

Korean VC firms invest in UK drug developer, first after Brexit

Celleron Therapeutics Ltd., a cancer treatment developer founded by Oxford University professors, is poised to attract $26 million from South Korean a...

Hanmi Pharm subsidiary JVM to sell fully automated drug inspection machines in US

Hanmi Pharmaceutical said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug dis...